News
The weight-loss drug Wegovy slashes the risk of heart disease even before people shed many pounds, data suggests.The drug, which contains the active ingredient semaglutide, works by reducing food ...
Ohio Attorney General Dave Yost sent letters to 14 medical spas warning them to stop making false or misleading claims about ...
For us, halfway through the 2020s, it’s Mounjaro vs Ozempic, the battle of the fat jabs. In the first ever head-to-head ...
Researchers have found in a new study that semaglutide could provide cardiovascular benefits to high-risk patients even ...
10h
Health on MSNWhy You Might Tolerate One Weight Loss Drug Better Than Another, According to ExpertsFact checked by Nick Blackmer Tirzepatide and semaglutide, the ingredients in popular weight loss drugs, can both cause side ...
New animal research being presented at this year's European Congress on Obesity (ECO) in Malaga, Spain (11-14 May), reveals distinct metabolic ...
A new analysis being presented at this year's European Congress on Obesity (ECO) in Malaga, Spain (11-14 May), finds that around half of the 100 top ...
People who take Wegovy appear to be at greater risk for hair loss, according to an early study that hasn't yet been ...
Vivani Chief Executive Officer Adam Mendelsohn, Ph.D., stated, "Our ongoing first-in-human study, LIBERATE-1, remains on track to deliver key data in mid-2025 with the aim of validating our ...
Zepbound — the brand name for tirzepatide — is the most effective GLP-1 medication for weight loss, according to one study.
Scientists herald 150 new jabs and pills to tackle obesity going through the research pipeline - but issue urgent warning to ...
Most Britons could soon use weight loss jabs to live longer, Britain’s most eminent medic has said. Experts hailed a “golden age” in obesity treatment thanks to drugs which have been found to halve ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results